Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study

Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study

In this study, we compared the similarities and differences in adverse events (AEs) among CAR T-cell products through signal mining via the FDA Adverse Event Reporting System (FAERS) and identified unknown AEs to provide a reference for safe clinical medication. Data from the FAERS database spanning...

Full description

Bibliographic Details
Main Authors: Zihan Guo, Yunlan Ding, Mengmeng Wang, Qing Zhai, Jiyong Liu, Qiong Du
Format: Article
Language:English
Published: MDPI AG 2024-08-01
Series:Pharmaceuticals
Subjects:
CAR T-cell therapy
adverse event
FAERS
real world
pharmacovigilance
Online Access:https://www.mdpi.com/1424-8247/17/8/1025

Internet

https://www.mdpi.com/1424-8247/17/8/1025

Similar Items